New clues identified in childhood cancer syndrome
New research from David Gutmann, MD, PhD, may help doctors determine which medical issues are likely to manifest in patients with the inherited cancer syndrome neurofibromatosis type 1 (NF1). The findings indicate that varying mutations in the NF1 gene may lead to different clinical outcomes.
Study reveals new, potent way to boost immunity and fight viruses
Studying mice with a variety of viral infections, scientists at the School of Medicine have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate. The findings reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses.
Combo of 3 antibiotics can kill deadly staph infections
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to researchers at Washington University School of Medicine in St. Louis. They have killed the bug — methicillin-resistant Staphylococcus aureus (MRSA) — in test tubes and laboratory mice, and believe the same strategy may work in people.
Drug-resistant bacteria possess natural ability to become vulnerable to antibiotics
Infections with one of the most troublesome and least
understood antibiotic-resistant “superbugs” are increasing at alarming
rates, particularly in health-care settings. But by studying A. baumannii, a frequent cause of difficult-to-treat infections in hospitals, researchers have identified a naturally occurring process that restores its vulnerability to antibiotics.
A person’s diet, acidity of urine may affect susceptibility to UTIs
The acidity of urine — as well as the presence of small molecules related to diet — may influence how well bacteria can grow in the urinary tract, a new study shows. The research, led by Jeffrey Henderson, MD, PhD, at Washington University School of Medicine in St. Louis, may have implications for treating urinary tract infections, which are among the most common bacterial infections worldwide.
Harder-to-abuse OxyContin doesn’t stop illicit use
A reformulation of OxyContin (left) that makes it less likely to be abused than the older formulation (right) has curtailed the drug’s illicit use. But researchers at the School of Medicine have found that a significant percentage still abuse the drug despite package labeling that emphasizes its abuse-deterrent properties.
Possible treatments identified for highly contagious stomach virus
Antibiotics aren’t supposed to be effective against viruses, but new evidence in mice suggests they may help fight norovirus, a highly contagious virus that causes severe gastrointestinal illness, scientists at the School of Medicine report.
Genetic errors linked to more ALS cases than scientists had thought
Genetic mutations may cause more cases of amyotrophic
lateral sclerosis (ALS) than scientists previously had realized, according
to researchers. Shown are study authors Janet Cady, a PhD candidate, and Matthew Harms, MD, assistant professor of neurology at the School of Medicine.
New treatment for Marfan syndrome shows promise
An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, according to a new study co-authored by Alan C. Braverman, MD. Slowing aortic growth in Marfan syndrome is important in protecting against the tearing of the aorta.
Fighting parasitic infection inadvertently unleashes dormant virus
Signals from the immune system that help repel a common parasite inadvertently can cause a dormant viral infection to become active again, a new study from the School of Medicine shows. Pictured is a helminth parasite.
Older Stories